<div id="readability-page-1"><div>Lin Elizabeth Yeu Officer of Tarsus Pharmaceuticals Inc [TARS] filed a Form 4 on December 17, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>12/15/25</td><td>Exercise</td><td>6,819</td><td>$0.00</td><td>N/A</td></tr><tr><td>12/16/25</td><td>Surrender(1)</td><td>2,078</td><td>$79.50</td><td>$165,201</td></tr></tbody></table></div>Ending Holdings: 40,341 (21,941 - Direct, 18,400 - Indirect)<ul><li>(1)</li><li>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

TARS

Lin Elizabeth Yeu, an officer of Tarsus Pharmaceuticals Inc, filed a Form 4 with the SEC on December 17, 2025, disclosing changes in ownership. On December 15, 2025, she exercised 6,819 shares at $0.00, and on December 16, 2025, surrendered 2,078 shares at $79.50, valued at $165,201, to cover option exercise costs and/or tax liabilities. Her ending holdings are 40,341 shares, with 21,941 direct and 18,400 indirect.

Officer Lin Acquires 4,741 Of Tarsus Pharmaceuticals Inc [TARS]